TickerFactsScreenerDevelopers

Grace Therapeutics, Inc. (GRCE) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2020: -$22.95M2021: -$14.32M2022: -$17.23M2023: -$15.91M2024: -$12.33M2025: -$14.90M-$14.90M
2020Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$14.90M-20.8%
2024-$12.33M+22.5%
2023-$15.91M+7.7%
2022-$17.23M-20.4%
2021-$14.32M+37.6%
2020-$22.95M—